MindTech

By: Manu Sidhu MD
  • Summary

  • Diving deep into unsolved problems in mental health - with the people building technology to solve them.
    Manu Sidhu, MD
    Show More Show Less
Episodes
  • A Breakthrough in Brainwaves - Rufus Mitchell-Heggs (Co-founder of Connectome) - #16
    Apr 24 2025

    Rufus Mitchell-Heggs is the Co-founder & Chief Scientific Officer of Connectome - a neurotechnology company transforming how we understand and optimise the human brain.

    Connectome’s mission is to make advanced brain insights accessible to everyone, starting with a non-invasive scan, and over time building the world’s largest longitudinal brain dataset.

    In this episode, we discuss how Rufus and his team are focused on:

    1. Only providing metrics that people can act on

    2. The surprising customer segment raving about this technology

    3. Balancing the tension between ‘moving fast and breaking things’ with ‘doing things properly’

    You will also get to see Rufus demoing the headset himself!

    If you’d like to participate in Connectome’s upcoming:

    • Study at Imperial College London, you can sign up to their waitlist here.

    • Round of fundraising, feel free to reach out to Rufus directly on LinkedIn.

    Access the MindTech Matrix⁠ - see where Connectome sits on the first and only map of mind health technology startups organised by the problem they’re solving and the solution they’re building.

    Links mentioned in the podcast episode:

    • ⁠Neurotechnology Funding Snapshot (2024)⁠

    • ⁠40% of Dementia Cases are Preventable⁠

    • ⁠Biomarkers: What Makes One Great?⁠

    • ⁠It Takes an Average of 17 Years for Evidence to Change Practice⁠

    Show More Show Less
    37 mins
  • Unleashing the Power of Neurodivergence - Steph Hamill (Founder, Investor & Consultant) - #15
    May 7 2024

    Neurodivergence can be a superpower if supported appropriately. In fact, 40-50% of founders are neurodivergent, indicating its potential for creativity and innovation. However, many are held back by the challenges that come with it.

    Steph Hamill is solving this problem as the Co-Founder of Divergence Supplements. Their lead product, Gamma Focus, is the first natural superblend specifically formulated to support the needs of divergent minds.

    Steph began her career in marketing, business development, and innovation. She now exclusively applies this expertise to making a social impact, such as in her role as senior entrepreneur-in-residence and MBA faculty for Oneday, an EdTech accelerator that supports entrepreneurs in launching and scaling their businesses. She has personally mentored over 250 founders.

    Steph was also the first investor for Mettle - the first mental fitness toolkit for men - which featured on MindTech as our very first episode.

    In this episode, we discuss:

    • Steph’s personal experience of being treated for neurodivergence, which gave her the insight to create a thriving business in this space

    • Redefining neurodivergence and unleashing its advantages

    • Facilitating community with conversational AI

    Steph is currently writing a book on neurodivergent entrepreneurs. So, if you are a neurodivergent entrepreneur, you can reach out to Steph on LinkedIn.

    Access the MindTech Matrix - the first map of mental health technology startups organised by the problem they’re solving and the solution they’re building.

    Discover insights & tools for your mind at ⁠The Mind, Explored.⁠

    Show More Show Less
    1 hr and 2 mins
  • Superconnecting the Ecosystem of YPMH - Peter Templeton (Founder of YPMH) - #14
    Apr 30 2024

    In children, existing treatments for depression are effective in only 60% of cases. After treatment, 50 - 75% experience a relapse. Why are these outcomes so poor? And how can we make progress?

    In this episode, we answer these questions and discuss:

    1. 3 overlooked factors contributing to young people’s mental health
    2. How parents can better support their children through mental health challenges
    3. How to measure DSM-5 outcomes in fewer questions for young people

    Peter Templeton founded The William Templeton Foundation for Young People’s Mental Health (YPMH) - a charitable foundation working to improve the lives of young people by facilitating innovation to resolve mental health conditions.

    On June 19th 2024, YPMH are co-hosting ‘Collaborate to innovate: Working together to transform mental health outcomes’ at the University of Cambridge. Each session is relevant to MindTech, but the one I am most looking forward to is the middle session on evaluating and prioritising innovations. Learn more and buy tickets here.

    Access the MindTech Matrix - the first map of mental health technology startups organised by the problem they’re solving and the solution they’re building.

    Discover insights & tools for your mind at ⁠The Mind, Explored.⁠

    Show More Show Less
    48 mins

What listeners say about MindTech

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.